UNICANCER - Centre Oscar Lambret
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RYCKEWAERT, Thomas
TANGENT, NCT05417789: Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

Recruiting
3
128
Europe, Canada, US, RoW
Emactuzumab, Placebo
SynOx Therapeutics Limited
TGCT
04/26
09/27
LENVAGIST, NCT04193553: Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

Completed
2
77
Europe
Lenvatinib, Placebo, Best supportive care
Centre Leon Berard
Gastro Intestinal Stromal Tumour
01/24
04/24
EREMISS, NCT03793361: Phase II Study of Regorafenib as Maintenance Therapy

Completed
2
127
Europe
Regorafenib, stivarga, Placebo
Centre Oscar Lambret
Metastatic Soft Tissue Sarcoma
03/24
09/24
EDEN, NCT05529251: De-escalation Study for Stage IIa/IIb < 3 cm Seminoma

Recruiting
2
90
Europe
Radiotherapy boost, Carboplatin AUC7, 3 cycles of EP
Centre Leon Berard
Seminoma, Stage II
09/25
09/30
RNASARC, NCT03375437: - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

Active, not recruiting
N/A
376
Europe
Blood and tumor samples
Centre Leon Berard, Hoffmann-La Roche
Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer
12/24
12/25

Download Options